SCHEMBL8937410

SCHEMBL8937410

CCOc1ccc(/C(=C/C(=O)N2CCN(C(=O)c3cc(OC)c(OC)c(OC)c3)CC2)c2ccccc2)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
CYP1A2 P05177 1/20 0.61
L3MBTL1 Q9Y468 2/20 0.58
HPGD P15428 1/20 0.58
ALOX15 P16050 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
TSHR P16473 1/20 0.52
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.50
CYP2C19 P33261 1/20 0.50
CDK5 Q00535 1/20 0.50
CDK5R1 Q15078 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TP53 P04637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937415 1.00 ALDH1A1 (0.61) ALDH1A1CYP1A2L3MBTL1HPGDALOX15
SCHEMBL8937413 1.00 ALDH1A1 (0.61) ALDH1A1CYP1A2L3MBTL1HPGDALOX15
SCHEMBL8937601 0.92 HPGD (0.60) ALDH1A1CYP1A2L3MBTL1HPGDSMN1; SMN2
SCHEMBL8937598 0.92 HPGD (0.60) ALDH1A1CYP1A2L3MBTL1HPGDSMN1; SMN2
SCHEMBL8937707 0.92 ALDH1A1 (0.70) ALDH1A1CYP1A2L3MBTL1SMN1; SMN2KDM4E
SCHEMBL8937708 0.92 ALDH1A1 (0.70) ALDH1A1CYP1A2L3MBTL1SMN1; SMN2KDM4E
SCHEMBL8937329 0.92 ALDH1A1 (0.58) ALDH1A1CYP1A2L3MBTL1HPGDSMN1; SMN2
SCHEMBL8937335 0.92 ALDH1A1 (0.58) ALDH1A1CYP1A2L3MBTL1HPGDSMN1; SMN2
SCHEMBL8937331 0.92 ALDH1A1 (0.58) ALDH1A1CYP1A2L3MBTL1HPGDSMN1; SMN2
SCHEMBL8937455 0.91 L3MBTL1 (0.54) ALDH1A1CYP1A2L3MBTL1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP claimed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US claimed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP claimed
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed